Anna Stochmal

501 total citations
22 papers, 309 citations indexed

About

Anna Stochmal is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Anna Stochmal has authored 22 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Dermatology and 6 papers in Epidemiology. Recurrent topics in Anna Stochmal's work include Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Anna Stochmal is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Anna Stochmal collaborates with scholars based in Poland, United States and Italy. Anna Stochmal's co-authors include Lidia Rudnicka, Joanna Czuwara, Maria Trojanowska, Jakub Żółkiewicz, Mariusz Sikora, Jolanta Małyszko, Joanna Matuszkiewicz‐Rowińska, Małgorzata Olszewska, Anna Waśkiel‐Burnat and Kalina Kawecka−Jaszcz and has published in prestigious journals such as PLoS ONE, Metabolism and Journal of Hypertension.

In The Last Decade

Anna Stochmal

20 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Stochmal Poland 9 186 92 88 73 70 22 309
Yuri Masui Japan 14 230 1.2× 102 1.1× 119 1.4× 131 1.8× 55 0.8× 30 452
R Rondinone Italy 10 101 0.5× 111 1.2× 88 1.0× 57 0.8× 123 1.8× 19 366
Claudia Bonino Italy 9 213 1.1× 64 0.7× 54 0.6× 85 1.2× 49 0.7× 10 330
Sabrina Hoa Canada 12 229 1.2× 140 1.5× 82 0.9× 93 1.3× 71 1.0× 24 397
Salvatore Lupoli Italy 8 200 1.1× 40 0.4× 56 0.6× 101 1.4× 106 1.5× 12 339
Emi Nishimagi Japan 8 218 1.2× 55 0.6× 81 0.9× 120 1.6× 49 0.7× 13 360
Adriana Severino Italy 8 225 1.2× 69 0.8× 53 0.6× 97 1.3× 80 1.1× 11 312
Saeedeh Shenavandeh Iran 10 134 0.7× 63 0.7× 85 1.0× 62 0.8× 129 1.8× 43 345
Katie Stewart United States 9 83 0.4× 34 0.4× 33 0.4× 101 1.4× 99 1.4× 14 295
Chi‐Yuan Tzen Taiwan 11 290 1.6× 57 0.6× 200 2.3× 28 0.4× 37 0.5× 31 573

Countries citing papers authored by Anna Stochmal

Since Specialization
Citations

This map shows the geographic impact of Anna Stochmal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Stochmal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Stochmal more than expected).

Fields of papers citing papers by Anna Stochmal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Stochmal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Stochmal. The network helps show where Anna Stochmal may publish in the future.

Co-authorship network of co-authors of Anna Stochmal

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Stochmal. A scholar is included among the top collaborators of Anna Stochmal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Stochmal. Anna Stochmal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stochmal, Anna, et al.. (2023). The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis. Advances in Medical Sciences. 68(2). 298–305. 1 indexed citations
2.
Stochmal, Anna, et al.. (2022). Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis. Clinical Reviews in Allergy & Immunology. 63(2). 289–296. 24 indexed citations
3.
Waśkiel‐Burnat, Anna, et al.. (2022). Lipocalin-2 and insulin as new biomarkers of alopecia areata. PLoS ONE. 17(5). e0268086–e0268086. 6 indexed citations
4.
Waśkiel‐Burnat, Anna, Aleksandra Gąsecka, Anna Stochmal, et al.. (2022). Patients with alopecia areata are at risk of endothelial dysfunction: results of a case–control study. Clinical and Experimental Dermatology. 47(8). 1517–1522. 5 indexed citations
5.
Stochmal, Anna, et al.. (2021). Metabolic mediators determine the association of antinuclear antibody subtypes with specific clinical symptoms in systemic sclerosis. Advances in Medical Sciences. 66(1). 119–127. 3 indexed citations
6.
Rudnicka, Lidia, et al.. (2021). Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review. Journal of Clinical Medicine. 10(19). 4517–4517. 10 indexed citations
7.
Stochmal, Anna, et al.. (2021). Epoprostenol up-regulates serum adiponectin level in patients with systemic sclerosis: therapeutic implications. Archives of Dermatological Research. 313(9). 783–791. 4 indexed citations
8.
Małyszko, Jolanta, et al.. (2020). Renal Involvement in Systemic Sclerosis: An Update. Kidney & Blood Pressure Research. 45(4). 532–548. 41 indexed citations
9.
Stochmal, Anna, et al.. (2020). BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS. Wiadomości Lekarskie. 73(10). 2300–2305. 12 indexed citations
10.
Stochmal, Anna, et al.. (2019). Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis. Archives of Dermatological Research. 312(6). 453–458. 19 indexed citations
11.
Żółkiewicz, Jakub, et al.. (2019). Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis. Advances in Dermatology and Allergology. 37(6). 921–926. 4 indexed citations
12.
Żółkiewicz, Jakub, Anna Stochmal, & Lidia Rudnicka. (2019). The role of adipokines in systemic sclerosis: a missing link?. Archives of Dermatological Research. 311(4). 251–263. 38 indexed citations
13.
Stochmal, Anna, Joanna Czuwara, Maria Trojanowska, & Lidia Rudnicka. (2019). Antinuclear Antibodies in Systemic Sclerosis: an Update. Clinical Reviews in Allergy & Immunology. 58(1). 40–51. 102 indexed citations
14.
Stochmal, Anna, et al.. (2018). Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy. Dermatology Review. 105(5). 604–612.
15.
Klocek, Marek, et al.. (2009). Modification of diet in renal disease (MDRD) and Cockcroft-Gault equations in estimation of glomerular filtration rate in patients with coronary artery disease and hypertension. Arterial Hypertension. 13(2). 97–105.
16.
Stochmal, Anna, et al.. (2007). [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].. PubMed. 64(6). 410–5. 1 indexed citations
17.
Surdacki, Andrzej, Stefanie M. Bode‐Böger, Jens Martens‐Lobenhoffer, et al.. (2006). Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance. Metabolism. 56(1). 77–86. 19 indexed citations
18.
Czarnecka, Danuta, et al.. (2005). Association of coronary atherosclerosis with insulin resistance in patients with impaired glucose tolerance. Acta Cardiologica. 60(3). 325–331. 2 indexed citations
19.
Stochmal, Anna, et al.. (1995). Relation between insulinaemia and lipoprotein composition in men with primary arterial hypertension with and without hypertriglyceridaemia.. PubMed. 9(2). 113–7. 3 indexed citations
20.
Stochmal, Anna, et al.. (1993). Very-low-density lipoprotein composition and endogenous insulin response in primary hypertension. Journal of Hypertension. 11(5). S278???S279–S278???S279. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026